Hunan Cancer Hospital
Clinical trials sponsored by Hunan Cancer Hospital, explained in plain language.
-
New combo targets hard-to-treat lung cancer in early trial
Disease control Not yet recruitingThis study tests a drug called firmonertinib combined with radiation therapy for people with stage III lung cancer that has specific genetic changes (EGFR uncommon mutations) and cannot be removed by surgery. The goal is to see if the combination can delay cancer growth or improv…
Phase: PHASE2 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 11:55 UTC
-
New hope for advanced breast cancer: drug combo trial targets resistant tumors
Disease control Not yet recruitingThis early-phase trial tests a combination of the drug sacituzumab govitecan with hormone therapy in 12 people whose HR-positive, HER2-negative metastatic breast cancer has worsened after standard CDK4/6 inhibitor treatment. The main goal is to check safety and tolerability, whil…
Phase: PHASE1 • Sponsor: Hunan Cancer Hospital • Aim: Disease control
Last updated May 17, 2026 11:53 UTC